Search Results for Feinstein

Debrief: Bob Brill, Newlight Management

A former GM at Harris Corp. — where he revolutionized commercial microprocessors — and an IBM engineer, the accomplished and always busy Bob Brill was also CEO of tech companies Algorex Corp. and Sipex Corp., all of which put his PhD in physics (Brown University) and undergraduate engineering degrees (Lehigh) to good use. Brill’s also a leading Long Island investor: The managing partner of Jericho investment firm Newlight Management and former general partner at VC…


No. 59: Buncee up, Quirky down and the earliest look at Pluto

THE BIG PUSH: Stony Brook University Medical Center is prepping to deliver its 100,000th baby in the next week or two. Stay tuned. SMART TECH: Calverton-based buncee was voted app of the week by leading ed platform Haiku Learning. THOUGHT THEY ALREADY HAD: Uber overtook taxis as the most expensed form of ground transportation in America in the second quarter, leaping 9 percentage points over Q1.


From potatoes to chips, innovation got us here

By JOHN KOMINICKI // Long Island has always taken great pride in being its own place – as the Cradle of Aviation, as a World War II manufacturing hub and America’s first suburb. Over the years it’s bragged about its oysters and potatoes, about building the Apollo moon lander and producing wines so good the locals couldn’t afford them. For the most part, we still can’t. Most recently, Long Island has focused on becoming the nation’s…


No. 58: Russ Artzt, bio-Legos and a brief mention of unmentionables

STATE OF THE ARTZT: CA Technologies cofounder Russ Artzt has announced plans to retire. Not to us, of course, but that’s the word leaking out of Islandia. BIG PAYDAY: Converting Uber’s 45,000 California drivers from contractors to part-time employees, as a lawsuit there is demanding, would cost the ride-sharing giant 10 percent of current revenue, according to analysis by Re/Code. And it could probably afford the $210M annual hit. Of course, that’s just California. Imagine what Uber’s…


Symbiotoc Health CEO Gerard Honig

Symbiotic Health gets $100K in funding

By GREGORY ZELLER // A spinoff of the Feinstein Institute for Medical Research has snagged a critical $100,000 stake from Accelerate Long Island and the Long Island Emerging Technologies Fund – good news for anyone suffering from the most prevalent hospital-based infection in the United States. Symbiotic Health, which does battle against the insidious Clostridium difficile infection, announced today that Accelerate Long Island has matched the $50,000 investment the LIETF fund made in June –…


No. 53: An energy plan, a Tinder for business and why we no longer love eel pie

IT WAS ONLY A MATTER OF TIME: Two driverless prototype cars had a near miss on a Silicon Valley street last week when a Google-operated Lexus RX400 cut off an Audi Q5 being tested by Delphi Automotive. No crash or injuries, but the cars were said to have exchanged digital threats and profanity. DON’T WASTE IT: You’ll get a little bit of extra time tomorrow as scientists in charge of keeping the planet’s clocks in alignment add…


No. 43: Jurassic Real, PalliaTech puffs up and Ikea sees the light

RAGE OF THE MACHINE: There is no shortage of angst about the relentless advance of digital technology and what it means for the workforce, if not humanity. But new research suggests we should chill already. NYT CERTAINLY SOMETHING TO CHEW ON: As NYC composting mandates start to kick in, Frank Celli, CEO of Rockland County-based BioHitech America, is pushing his aerobic digesters – they’re like a “mechanical stomach,” he says – that can plow through…


No. 40: Trustpilot, more drones and a very pricey pinot

PINOT, A FILM NOIR: Thieves have been busting into the wine cellars of Michelin-starred California eateries and making off with some of the world’s most-select vintages, including $25K botttles of Domaine de la Romanée-Conti, one of the most prized pinots ever bottled. They leave the rest. Could it be robbery for hire? Bloomberg’s Claire Suddath. KRIMINAL ACT: Dutch and German detectives resorted to their own trickery to track down a pair of bronze horses commissioned for Adolf…


No. 35: Text therapy, a dip in women’s biz and a hot new hangover cure

STATE OF MS. BIZ: Women opened just 37% of new businesses last year, down from a 20-year average of about 41%, according to a study by Experian. Women were most likely to launch beauty shops, retail stores and personal-service businesses. A cool infographic GLWT: Pine Plains-based Talkspace, a texting service that connects the troubled with their therapists, landed a $9.5M investment, the first in the mental-healthtech arena. Boston’s Spark Capital and New York’s SoftBank Capital led the series…


No. 33: Uber at $50B, a chocolate cure and how dude are you?

LOOKING TO THE SUBURBS: There’s an inconvenient truth tucked into the environmental sustainability plan for New York that Mayor Bill de Blasio unveiled last month: The city needs the suburbs to solve its housing problem. With rents soaring and too few new apartments for the city’s growing population, the ‘burbs hold vast potential for multifamily housing along the veins of the region’s public transit network. The problem? More than 100 governments in counties, cities, towns and…


Symbiotoc Health CEO Gerard Honig

Leading the fight against C. Diff

By GREGORY ZELLER // Researchers battling the insidious clostridium difficile infection are making progress on several new fronts, including a novel “poop pill” developed by Symbiotic Health, a spinoff from North Shore-LIJ’s Feinstein Institute. C. Diff, as it is known, is the most prevalent hospital-acquired infection in the United States and “an immediate public health threat,” according to the Centers for Disease Control. The infection attacks the gastrointestinal tract when broad-spectrum antibiotics fight off infections but…


Goddard Labs snags biotech honor

Goddard Labs, a Calverton-based startup that has developed breakthrough food and water testing technology, has been named Best in Show of the Mid Atlantic Bio Angels’ 1st Pitch Life Sciences competition. Although the physical prize isn’t much — a polo shirt and a press release — the bragging rights are gold plated and the connections may one day be worth even more: MABA members are active investors from Delaware to Massachusetts with deep backgrounds in…


festo robot zoo

No. 26: Schein on Stanley Bergman, killer weed for Wallkill and loud love in Brooklyn

TGIF: A good Friday everyone, and welcome to new readers. Don’t forget to send tips, news, story ideas, calendar items, releases, promotions, job postings, criticisms and corrections to editor@innovateli.com. ROOT FOR THE HOME TEAM: Students from Molloy College, Stony Brook University and Farmingdale State College will face off today in the state finals of the NY business plan competition, which includes 75 schools from 10 regions and $500,000 in prizes. Molloy College student Mike Russo earned top honors…


Traverse CEO Joseph Scaduto

Traverse readies the move to market

BY GREGORY ZELLER // Armed with a just-executed licensing agreement for a suite of anti-inflammatory drug therapies, two-year-old Traverse Biosciences is stepping up efforts to land the investors and strategic partners necessary for rapid product development. The licensing agreement with the SUNY Research Foundation gives Traverse rights to compounds developed by Stony Brook University faculty members Lorne Golub and Francis Johnson and known as — science alert — polyenolic zinc-binding agents. Their leading drug candidate,…


No. 25: Mission impossible, inside innovation and Googling Nessie

TGIW: A good Wednesday and welcome to our newest readers. This roundup is for you, so please tell us how we can make it better. Send tips, news, ideas, calendar items, releases, promotions, job postings, criticisms and corrections to editor@innovateli.com. OPINION MISSION LONG ISLAND: Gov. Andrew M. Cuomo was in Cuba this week to push his Global New York strategy, which seeks to expand trade and other business opportunities for Empire State companies. At his side: executives from…